Spacer devices for inhaled therapy: why use them, and how?

Walter Vincken, Mark L. Levy, Jane Scullion, Omar S. Usmani, P.N. Richard Dekhuijzen, Chris J. Corrigan

Source: ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Walter Vincken, Mark L. Levy, Jane Scullion, Omar S. Usmani, P.N. Richard Dekhuijzen, Chris J. Corrigan. Spacer devices for inhaled therapy: why use them, and how?. ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to choose and use an inhaler device?
Source: Virtual Congress 2021 – Updates on inhalers for COPD and asthma
Year: 2021


Inhaled medication: which device for which patient?
Source: Eur Respir Monogr 2015; 69: 213-223
Year: 2015


The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013


Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

How patients use inhalers - what are the critical errors?
Source: International Congress 2017 – Advances in Inhaler technology - intuitive design and better drug delivery
Year: 2017


How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Inhaled antibiotics: a new tool?
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Year: 2004


Cough assist devices: what, when and how?
Source: International Congress 2019 – Sleep and neuromuscular diseases: assessment and management of respiratory problems
Year: 2019


Foundation doctor knowledge of inhaled devices - Are the old better than the new?
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016


Factors affecting choice of inhalers: who is choosing for whom?
Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies"
Year: 2007


Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Year: 2020



Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020
Year: 2020